Revvity SG&A Expenses 2010-2024 | RVTY
Revvity annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Revvity sg&a expenses for the quarter ending September 30, 2024 were $0.238B, a 5.09% decline year-over-year.
- Revvity sg&a expenses for the twelve months ending September 30, 2024 were $1.006B, a 0.37% decline year-over-year.
- Revvity annual sg&a expenses for 2023 were $1.023B, a 0.29% decline from 2022.
- Revvity annual sg&a expenses for 2022 were $1.026B, a 5.16% increase from 2021.
- Revvity annual sg&a expenses for 2021 were $0.975B, a 36.11% increase from 2020.
| Revvity Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $1,023 |
| 2022 | $1,026 |
| 2021 | $975 |
| 2020 | $716 |
| 2019 | $815 |
| 2018 | $812 |
| 2017 | $626 |
| 2016 | $590 |
| 2015 | $587 |
| 2014 | $648 |
| 2013 | $582 |
| 2012 | $627 |
| 2011 | $624 |
| 2010 | $487 |
| 2009 | $477 |
| Revvity Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $238 |
| 2024-06-30 | $252 |
| 2024-03-31 | $261 |
| 2023-12-31 | $257 |
| 2023-09-30 | $250 |
| 2023-06-30 | $267 |
| 2023-03-31 | $249 |
| 2022-12-31 | $244 |
| 2022-09-30 | $243 |
| 2022-06-30 | $263 |
| 2022-03-31 | $275 |
| 2021-12-31 | $166 |
| 2021-09-30 | $276 |
| 2021-06-30 | $282 |
| 2021-03-31 | $251 |
| 2020-12-31 | $62 |
| 2020-09-30 | $225 |
| 2020-06-30 | $221 |
| 2020-03-31 | $209 |
| 2019-12-31 | $211 |
| 2019-09-30 | $204 |
| 2019-06-30 | $202 |
| 2019-03-31 | $199 |
| 2018-12-31 | $211 |
| 2018-09-30 | $197 |
| 2018-06-30 | $205 |
| 2018-03-31 | $200 |
| 2017-12-31 | $176 |
| 2017-09-30 | $153 |
| 2017-06-30 | $150 |
| 2017-03-31 | $147 |
| 2016-12-31 | $152 |
| 2016-09-30 | $143 |
| 2016-06-30 | $151 |
| 2016-03-31 | $145 |
| 2015-12-31 | $147 |
| 2015-09-30 | $148 |
| 2015-06-30 | $147 |
| 2015-03-31 | $146 |
| 2014-12-31 | $206 |
| 2014-09-30 | $143 |
| 2014-06-30 | $147 |
| 2014-03-31 | $152 |
| 2013-12-31 | $140 |
| 2013-09-30 | $143 |
| 2013-06-30 | $148 |
| 2013-03-31 | $151 |
| 2012-12-31 | $175 |
| 2012-09-30 | $145 |
| 2012-06-30 | $150 |
| 2012-03-31 | $157 |
| 2011-12-31 | $220 |
| 2011-09-30 | $133 |
| 2011-06-30 | $138 |
| 2011-03-31 | $133 |
| 2010-12-31 | $122 |
| 2010-09-30 | $121 |
| 2010-06-30 | $123 |
| 2010-03-31 | $122 |
| 2009-12-31 | $111 |
| 2009-09-30 | $113 |
| 2009-06-30 | $124 |
| 2009-03-31 | $129 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.634B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| Cencora (COR) | United States | $48.280B | 17.81 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |